Contrast Enhanced Ultrasound Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Type, By End use, By Region and Competition, 2020-2030F

Description

The Global Contrast Enhanced Ultrasound Market, valued at USD 2.27 Billion in 2024, is projected to experience a CAGR of 4.65% to reach USD 2.98 Billion by 2030. Contrast-enhanced ultrasound (CEUS) is a diagnostic imaging modality that utilizes intravenously administered, gas-filled microbubbles to enhance the visualization of blood flow and tissue vascularization during standard medical sonography. This technique improves diagnostic precision by accentuating vascular patterns in organs and lesions, often providing clearer images than conventional ultrasound.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 2.27 Billion
Market Size 2030	USD 2.98 Billion
CAGR 2025-2030	4.65%
Fastest Growing Segment	Non-Targeted
Largest Market	North America

Key Market Drivers

The rising global burden of chronic diseases is a significant market driver for Contrast Enhanced Ultrasound. Conditions like cardiovascular disease, cancer, and hepatic disorders require accurate and frequent diagnostic imaging for early detection, staging, and monitoring treatment. CEUS provides a non-invasive, radiation-free method to precisely assess tissue perfusion and vascularity, which is crucial for characterizing lesions and evaluating organ function. This capability assists clinicians in making timely patient management decisions.

Key Market Challenges

The global scarcity of skilled sonographers poses a significant challenge to the growth of the Contrast Enhanced Ultrasound market. The sophisticated nature of CEUS procedures requires specialized expertise for accurate operation, image acquisition, and interpretation. Without an adequate pool of trained professionals, healthcare facilities face limitations in adopting and fully utilizing this advanced imaging modality, regardless of its diagnostic benefits.

Key Market Trends

AI integration is significantly enhancing contrast-enhanced ultrasound by improving image analysis and diagnostic capabilities. Artificial intelligence algorithms automate segmentation, anomaly detection, and optimize workflow, thereby improving accuracy and efficiency and potentially reducing human error. This technological advance enables faster interpretation of complex images and supports early disease detection, leading to improved patient outcomes. According to Medical Device Network, in July 2023, UltraSight received FDA approval for its AI-based cardiac ultrasound guidance technology, enabling medical professionals without prior sonography experience to capture diagnostic-quality images at the point of care.

Key Market Players

Lantheus Holdings, Inc.
General Electric Company
Siemens Healthineers Company
nanoPET Pharma GmbH
ESAOTE SPA
GE HealthCare Technologies, Inc.
Koninklijke Philips N.V.
Leriva SA

Report Scope:

In this report, the Global Contrast Enhanced Ultrasound Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Contrast Enhanced Ultrasound Market, By Product:

Equipment
Contrast Agents

Contrast Enhanced Ultrasound Market, By Type:

Non-targeted
Targeted

Contrast Enhanced Ultrasound Market, By End use:

Hospitals
Clinics
Ambulatory Diagnostic Centers

Contrast Enhanced Ultrasound Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Contrast Enhanced Ultrasound Market.

Available Customizations:

Global Contrast Enhanced Ultrasound Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Contrast Enhanced Ultrasound Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product (Equipment, Contrast Agents)
- 5.2.2. By Type (Non-targeted, Targeted)
- 5.2.3. By End use (Hospitals, Clinics, Ambulatory Diagnostic Centers)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
5.3. Market Map

6. North America Contrast Enhanced Ultrasound Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Type
- 6.2.3. By End use
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Contrast Enhanced Ultrasound Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product
    - 6.3.1.2.2. By Type
    - 6.3.1.2.3. By End use
- 6.3.2. Canada Contrast Enhanced Ultrasound Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product
    - 6.3.2.2.2. By Type
    - 6.3.2.2.3. By End use
- 6.3.3. Mexico Contrast Enhanced Ultrasound Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product
    - 6.3.3.2.2. By Type
    - 6.3.3.2.3. By End use

7. Europe Contrast Enhanced Ultrasound Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Type
- 7.2.3. By End use
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Contrast Enhanced Ultrasound Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product
    - 7.3.1.2.2. By Type
    - 7.3.1.2.3. By End use
- 7.3.2. France Contrast Enhanced Ultrasound Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product
    - 7.3.2.2.2. By Type
    - 7.3.2.2.3. By End use
- 7.3.3. United Kingdom Contrast Enhanced Ultrasound Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product
    - 7.3.3.2.2. By Type
    - 7.3.3.2.3. By End use
- 7.3.4. Italy Contrast Enhanced Ultrasound Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product
    - 7.3.4.2.2. By Type
    - 7.3.4.2.3. By End use
- 7.3.5. Spain Contrast Enhanced Ultrasound Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product
    - 7.3.5.2.2. By Type
    - 7.3.5.2.3. By End use

8. Asia Pacific Contrast Enhanced Ultrasound Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Type
- 8.2.3. By End use
- 8.2.4. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Contrast Enhanced Ultrasound Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product
    - 8.3.1.2.2. By Type
    - 8.3.1.2.3. By End use
- 8.3.2. India Contrast Enhanced Ultrasound Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product
    - 8.3.2.2.2. By Type
    - 8.3.2.2.3. By End use
- 8.3.3. Japan Contrast Enhanced Ultrasound Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product
    - 8.3.3.2.2. By Type
    - 8.3.3.2.3. By End use
- 8.3.4. South Korea Contrast Enhanced Ultrasound Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product
    - 8.3.4.2.2. By Type
    - 8.3.4.2.3. By End use
- 8.3.5. Australia Contrast Enhanced Ultrasound Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product
    - 8.3.5.2.2. By Type
    - 8.3.5.2.3. By End use

9. Middle East & Africa Contrast Enhanced Ultrasound Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Type
- 9.2.3. By End use
- 9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Contrast Enhanced Ultrasound Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product
    - 9.3.1.2.2. By Type
    - 9.3.1.2.3. By End use
- 9.3.2. UAE Contrast Enhanced Ultrasound Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product
    - 9.3.2.2.2. By Type
    - 9.3.2.2.3. By End use
- 9.3.3. South Africa Contrast Enhanced Ultrasound Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product
    - 9.3.3.2.2. By Type
    - 9.3.3.2.3. By End use

10. South America Contrast Enhanced Ultrasound Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Type
- 10.2.3. By End use
- 10.2.4. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Contrast Enhanced Ultrasound Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product
    - 10.3.1.2.2. By Type
    - 10.3.1.2.3. By End use
- 10.3.2. Colombia Contrast Enhanced Ultrasound Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product
    - 10.3.2.2.2. By Type
    - 10.3.2.2.3. By End use
- 10.3.3. Argentina Contrast Enhanced Ultrasound Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product
    - 10.3.3.2.2. By Type
    - 10.3.3.2.3. By End use

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Contrast Enhanced Ultrasound Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Lantheus Holdings, Inc.
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. General Electric Company
15.3. Siemens Healthineers Company
15.4. nanoPET Pharma GmbH
15.5. ESAOTE SPA
15.6. GE HealthCare Technologies, Inc.
15.7. Koninklijke Philips N.V.
15.8. Leriva SA